T-Target
Target discovery powered by AI, Big Data & Systems Biology.
Systems Biology Based Target Discovery
Unlock disease-central, controllable targets through multi-omics biological networks. Identify key associations between clinical chemistry, proteomics, metabolomics, and metagenomics to gain actionable insights into wellness and disease states.
Discover connections between different genes
Explore tissue- and cancer-specific Gene Co-expression Networks with precision. Analyze feature associations interactively across omics data and tailor insights based on specific contexts—such as sex-specific variations—for a more targeted and comprehensive understanding.
T-TARGET Provides Data-Driven Insights
Harness high-quality, diverse data sources, including GTEx, TCGA, and personalized wellness profiling studies. Access 100+ networks, spanning tissue- and cancer-specific, gender-specific, disease (IR/IS), cross-sectional, and delta networks. T-TARGET platform seamlessly integrates and normalizes multi-dimensional data, allowing you to focus on discovery while revealing complex gene interactions and biological mechanisms.
Plasma Metabolomics
LC-MS and/or GC-MS, relative abundance
Plasma Proteomics
LC-MS and/or GC-MS, relative abundance
Anthropometrics & Clinical Chemistry
BMI, Waist, Height, Blood and Urine tests
Oral & Gut Microbiome
16S profiling & shotgun metagenomics
Transcriptomics
RNA-seq data for tissues and cancers
T-Chat
T-Chat for T-Target coming soon.
Case Study: Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
We identify PKLR as a key regulator of NAFLD and reposition small-molecule inhibitors through a computational drug discovery pipeline, validating their efficacy in preclinical models.
Learn more about T-TARGET